Phillip Choi, BS

Articles by Phillip Choi, BS

Assessing the Chiral Switch: Approval and Use of Single-Enantiomer Drugs, 2001 to 2011

ByWalid F. Gellad, MD, MPH,Phillip Choi, BS,Margaret Mizah, PharmD,Chester B. Good, MD, MPH,Aaron S. Kesselheim, MD, JD, MPH

March 14th 2014

From 2001 to 2011, the US Food and Drug Administration approved 9 single-enantiomer drugs with racemic precursors. None showed pre-approval evidence of improved efficacy over the racemic precursor.

Latest Updated Articles

Assessing the Chiral Switch: Approval and Use of Single-Enantiomer Drugs, 2001 to 2011
March 14th 2014

Phillip Choi, BS

Articles by Phillip Choi, BS

Assessing the Chiral Switch: Approval and Use of Single-Enantiomer Drugs, 2001 to 2011

Latest Updated Articles

Trending on AJMC

Daraxonrasib Clears FDA as First RAS-Targeted Pancreatic Cancer Drug

New York Experts Push for Coordinated Obesity Care Teams

FDA Clears First Single-Biomarker Blood Test for Alzheimer

Grocery Assistance Benefit Linked to Fewer Diabetes Complications

Lung Cancer Task Force Maps Research Roadmap to Close Survival Gap